Business

Ligand to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

JUPITER, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026. The company will hold a conference call beginning at 8:30 a.m. ET to discuss the results and provide a general business update. Conference Call and Webcast Information Date: Thursday, February 26, 2026 Time: 8:30 AM Eastern Time Conference Call:(800) 715-9871 (U.S. & Canada)(646)

articleLigand Pharmaceuticals IncorporatedFebruary 12, 20262/company/ligand-pharmaceuticals-incorporated/news/ligand-report-fourth-quarter-full-120000324
Ligand to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

About this update from Ligand Pharmaceuticals Incorporated

[{"type":"image","alt":"Ligand Pharmaceuticals","displaySize":"","headline":null,"caption":"Ligand Pharmaceuticals","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":105,"url":"https://media.zenfs.com/en/globenewswire.com/e824ed3c4822e04f01467c6db4017595"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Yrpe7ervqRZN98EXhfJlGA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0NztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e824ed3c4822e04f01467c6db4017595","width":300,"height":105}},"lazy":false},{"type":"text","content":"JUPITER, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026. The company will hold a conference call beginning at 8:30 a.m. ET to discuss the results and provide a general business update.","length":347,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"2","style":"max-width:20%;width:100.023%;min-width:20%;vertical-align:top;","val":[{"type":"text","content":"Conference Call and Webcast Information","length":39,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"2","style":"max-width:20%;min-width:20%;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:23.7061%;vertical-align:top;","val":[{"type":"text","content":"Date:","length":5,"tagName":"p","attribs":{}}]},{"style":"width:76.317%;","val":[{"type":"text","content":"Thursday, February 26, 2026","length":27,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:23.7061%;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"style":"width:76.317%;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:23.7061%;vertical-align:top;","val":[{"type":"text","content":"Time:","length":5,"tagName":"p","attribs":{}}]},{"style":"width:76.317%;","val":[{"type":"text","content":"8:30 AM Eastern Time","length":20,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:23.7061%;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"style":"width:76.317%;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:23.7061%;vertical-align:top;","val":[{"type":"text...

More updates from Ligand Pharmaceuticals Incorporated

biopharmaceutical companyLigand Pharmaceuticalsdiversified portfoliobiotech industryplatform technology